Johnson & Johnson Reports Q4 and Full-Year 2021 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Johnson & Johnson Reports Q4 and Full-Year 2021 Results

Johnson & Johnson (JNJ) PT Raised to $163 at Goldman Sachs

January 26, 2022 7:36 AM EST

Goldman Sachs analyst Chris Shibutani raised the price target on Johnson & Johnson (NYSE: JNJ) to $163.00 (from $161.00) while maintaining a Neutral rating.

... More

Johnson & Johnson (JNJ) Tops Q1 EPS by 1c

January 25, 2022 6:28 AM EST

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.13, $0.01 better than the analyst estimate of $2.12. Revenue for the quarter came in at $24.8 billion versus the consensus estimate of $25.29 billion.

GUIDANCE:

Johnson & Johnson sees FY2022 EPS of $10.40-$10.60, versus the consensus of... More